About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
The University of Kansas Cancer Center
https://www.kucancercenter.org/
2023 Multidisciplinary Oncology Review
2022
Advances in Hematologic Malignancies and Cellular Therapeutics Symposium
2022 Post San Antonio Review
Videos
2021
2021 Virtual KU Hematology and Medical Oncology Review
2021 Post San Antonio Review
2021 KUMC Virtual Multidisciplinary Oncology Review
2020
ASH Review VIRTUAL 2020: Current Updates in Hematologic Diseases
2020 ASCO Highlights
2019
2019 Post San Antonio Breast Cancer Review
ASH 2019 Review: Current Updates in Hematologic Diseases
2019 Lung Cancer and Head & Neck Cancer Symposium
Hematology & Medical Oncology Review 2019
Lung
Hematologic Malignancies
Gastrointestinal
Head and Neck
Genitourinary
Skin
Palliative
General
Event
2018
ASH: Current Updates in Hematologic Diseases
Events
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
P
2019 Update on the HPV+ Oropharynx Carcinoma: Cisplatin and Concurrent Radiation Therapy Remain Standard of Care for Non-Smokers Eligible for Cisplatin Chemotherapy
By
2019 University of Kansas Lung Cancer and Head & Neck Cancer Symposium
FEATURING
Prakash Neupane
By
2019 University of Kansas Lung Cancer and Head & Neck Cancer Symposium
FEATURING
Prakash Neupane
32 views
November 12, 2019
0 Comments
Login to view comments.
Click here to Login
Featured Video
06:51
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Prevalence and Prediction of Ruxolitinib Tr…
Feat.
D. Tremblay
Featured Video
15:14
Icahn School of Medicine at Mount Sinai
Safety Profile of Ruxolitinib in Patients With MF
Feat.
D. Tremblay
2019 Lung Cancer and Head & Neck Cancer Symposium
08:12
2019 University of Kansas Lung Cancer and Head & Neck Cancer Symposium
Understanding the Distinction of HPV-Mediated (p16+) Oropharynx Canc…
Feat.
G. Gan
12:23
2019 University of Kansas Lung Cancer and Head & Neck Cancer Symposium
De-Escalation of HPV-Mediated (p16+) Oropharynx Cancer Treatment: Ra…
Feat.
G. Gan
10:27
2019 University of Kansas Lung Cancer and Head & Neck Cancer Symposium
De-Escalation of HPV-Mediated (p16+) Oropharynx Cancer Treatment: TO…
Feat.
G. Gan
19:34
2019 University of Kansas Lung Cancer and Head & Neck Cancer Symposium
Evaluation and Managing Options of the Adult Neck Mass in the Era of…
Feat.
A. Bur
06:51
2019 University of Kansas Lung Cancer and Head & Neck Cancer Symposium
2019 Update on the HPV+ Oropharynx Carcinoma: Cisplatin and Concurre…
Feat.
P. Neupane
06:20
2019 University of Kansas Lung Cancer and Head & Neck Cancer Symposium
2019 Update on Locally Advanced Nasopharyngeal Cancer: Induction Che…
Feat.
P. Neupane
08:21
2019 University of Kansas Lung Cancer and Head & Neck Cancer Symposium
2019 Update on Recurrent/Metastatic Head&Neck Squamous Cell Carc…
Feat.
P. Neupane
12:55
2019 University of Kansas Lung Cancer and Head & Neck Cancer Symposium
2019 Update on Salivary Gland Carcinoma: Anti-HER2 w/o or w/Chemo Do…
Feat.
P. Neupane
17:19
2019 University of Kansas Lung Cancer and Head & Neck Cancer Symposium
The Use of IO Agents in Metastatic NSCLC: Overview of Anti-PD-1/Anti…
Feat.
D. Gibbons
10:16
2019 University of Kansas Lung Cancer and Head & Neck Cancer Symposium
Immunotherapy in Advanced NSCLC: Difficulties With Biomarkers Develo…
Feat.
D. Gibbons
13:33
2019 University of Kansas Lung Cancer and Head & Neck Cancer Symposium
Checkpoint Inhibitors in Stage III NSCLC (Pacific Trial Regimen) / B…
Feat.
D. Gibbons
17:11
2019 University of Kansas Lung Cancer and Head & Neck Cancer Symposium
Microbiome as a Predictive Ecosystem for Immunotherapy in NSCLC Can …
Feat.
J. Zhang
12:42
2019 University of Kansas Lung Cancer and Head & Neck Cancer Symposium
New KRAS G12C / MET Exon 14 TKI’s for Advanced NSCLC: Favorable Safe…
Feat.
C. Huang
22:41
2019 University of Kansas Lung Cancer and Head & Neck Cancer Symposium
New TKI’s in Development for Lung Cancer. An Overview of New ROS1 / …
Feat.
C. Huang
